Abstract: A synbiotic composition for use in the amelioration, treatment, reductions of symptoms of a neuropsychiatric disorder and/or the reduction of side effects of a pharmacological treatment of a neuropsychiatric disorder. The synbiotic composition includes at least two bacterial strains chosen from the group consisting of Lactobacillus plantarum, Lactobacillus paracasei, Pediococcus pentosaceus, Leuconostoc mesenteroides, and Bifidobacterium breve; and at least one dietary fibers chosen from the group consisting of inulin, pectin, beta-glucan, resistant starch, a galacto-oligosaccharide, an isomalto-oligosaccharide and a rice fiber.

Abstract: The present application relates to a synbiotic composition for use in the prevention, amelioration, treatment, or reductions of symptoms in an individual suffering from Inflammatory Bowel Disease (IBD) or from an infection with a respiratory virus or from long-term effects after an infection with a respiratory virus, wherein the synbiotic composition comprises at least two bacterial strains chosen from the group consisting of Lactobacillus plantarum, Lactobacillus paracasei, Pediococcus pentosaceus, Leuconostoc mesenteroides, and Bifidobacterium breve; and at least one dietary fibers chosen from the group consisting of inulin, pectin, beta-glucan, resistant starch, a galacto-oligosaccharide, an isomalto-oligosaccharide and rice fibers.

Abstract: An isolated nucleic acid molecule comprising a nucleotide sequence derived from a vertebrate animal, said nucleotide sequence codes for a polypeptide that is capable of at least partially complementing the phenotype of an animal having the anx/anx genotype as described in Maltais et al., J. Hered., 1984, 75:468-472, or a similar genotype and the polypeptide encoded by the nucleotide sequence is useful for controlling food or feed intake or body weight in animals including humans. Antibodies to the polypeptide can be used as diagnostic agents or for therapeutic purposes. Receptors for the polypeptide or antibodies to the receptors and/or polypeptide can be used to block, inhibit or enhance the biological activity of the polypeptide.

Abstract: Methods of detecting expanded nucleotide repeats in genomic DNA in a biological sample are disclosed and methods for the diagnosis of pathological and potentially pathological conditions in an individual based on the detection of the presence of expanded nucleotide repeats.